BioValley - The Life Science Network - was founded in 1996. The vision of the founders was to bring together Alsace (France), South Baden (Germany) and Northwestern Switzerland. It was one of the first European initiatives for the promotion and development of life sciences.
The three border regions Alsace, northwest Switzerland and South Baden stood out individually in the mid-90s for their outstanding potential in the field of life sciences:
- Outstanding scientific facilities (four universities, specialised colleges of higher education, research centres, etc.),
- Headquarters of global players Novartis and Roche as well as CIBA, Clariant, Lonza and Syngenta,
- Branches of large pharmaceutical companies, such as DSM, Johnson & Johnson, Eli Lilly, Pfizer, Sanofi-Aventis, DuPont, Amersham and Millipore,
Today, the BioValley cluster compromises three associations (Alsace BioValley, BioValley Deutschland and BioValley Basel) and the BioValley Platform in Germany. Our joint mission:
- A network of competences and know-how which includes companies, research institutes, universities as well as economic development agencies and public organizations the field of Life Sciences.
- The BioValley Cluster accompanies businesses and laboratories in the Life Sciences sector looking to innovate, grow or locate in the trinational BioValley region
See our the links to the Network for further detail.
Members of the Board
- Matthias Staehelin, VISCHER, Basel (President)
- Nicolas Benedict, CEO, Allecra Therapeutics, F-St. Louis
- Edwin Constable, Vice-Rector Research, University of Basel
- Nicholas Franco, EVP, Actelion, Allschwil
- Neil Goldsmith
- Rudolf Gygax, Nextech Ventures, Zurich
- Thomas Möller, BioMed Partners AG, Basel (Treasurer)
- Peter Räber, Energie Zukunft Schweiz, Basel
- Zaki Sellam, CEO, Avicenna Oncology GmbH, Basel